Astera Labs Chief Executive Maintains Large Stake Despite $5.3M Stock Sale
Rhea-AI Filing Summary
Astera Labs CEO Jitendra Mohan executed planned sales of common stock on June 20, 2025, through a pre-established Rule 10b5-1 trading plan from December 2024. The transactions involved the sale of approximately 52,743 shares at weighted average prices ranging from $100.00 to $101.73 per share.
The sales were distributed across multiple trusts:
- Living Trust: 8,790 shares (remaining: 4,342,220 shares)
- Trust: 8,793 shares (remaining: 762,210 shares)
- 2021 Trust 1 & 2: 8,790 shares each (remaining: 762,217 shares each)
- 2022 Trust 1 & 2: 8,790 shares each (remaining: 512,218 shares each)
Mohan maintains direct ownership of 2,262,318 shares and serves as both Director and CEO. The filing includes standard disclaimers regarding beneficial ownership of trust-held securities.
Positive
- None.
Negative
- None.
Insights
CEO Jitendra Mohan sold 52,743 shares (~$5.3M) via planned 10b5-1 sales while maintaining substantial 9.9M share position across multiple trusts.
This Form 4 filing reveals that Astera Labs CEO and Director Jitendra Mohan sold 52,743 shares on June 20, 2025, at an average price of $100.86 per share, generating approximately $5.3 million. The transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on December 2, 2024, which allows insiders to sell shares at predetermined times regardless of potential material non-public information they may possess.
Despite this sale, Mohan retains significant ownership in Astera Labs with approximately 9.92 million shares across multiple ownership structures: 2.26 million shares held directly and 7.65 million shares held indirectly through various trusts. The largest position is 4.34 million shares in a Living Trust, with additional holdings distributed across five other trust entities ranging from 512,218 to 762,217 shares each.
The structured nature of these sales across six different trust entities in nearly identical amounts (approximately 8,790 shares each) suggests careful estate planning rather than an urgent liquidation. This systematic selling represents only about 0.5% of Mohan's total holdings, indicating this is likely part of a routine diversification strategy rather than a significant reduction in his position. The CEO's continued substantial ownership aligns his interests with long-term shareholders despite this modest reduction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 8,790 | $100.8573 | $887K |
| Sale | Common Stock | 8,793 | $100.8573 | $887K |
| Sale | Common Stock | 8,790 | $100.8573 | $887K |
| Sale | Common Stock | 8,790 | $100.8573 | $887K |
| Sale | Common Stock | 8,790 | $100.8573 | $887K |
| Sale | Common Stock | 8,790 | $100.8573 | $887K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 27,056 shares sold at prices ranging from $100.0000 to $100.9900, and 25,687 shares sold at prices ranging from $100.9950 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
